LBF232nnPG03: Difference between revisions
No edit summary |
No edit summary |
(No difference)
|
Revision as of 10:00, 25 February 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1794 |
LipidMaps | LMFA03010123 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF232nnPG03 |
17-phenyl trinor Prostaglandin F_2α amide | |
---|---|
![]() | |
Structural Information | |
9α,11α,15S-trihydroxy-17-phenyl-18,19,20-trinor-5Z,13E-dien-1-amide | |
| |
Formula | C23H33NO4 |
Exact Mass | 387.24095854899997 |
Average Mass | 387.51246 |
SMILES | C(c(c2)cccc2)C[C@@H](C=C[C@H]([C@H]1CC=CCCCC(N)=O)[C@@H](C[C@H](O)1)O)O |
Physicochemical Information | |
17-phenyl trinor PGF2 alpha amide is expected to show the typical intraocular effects of latanoprost. In vivo study revlealed that 17-phenyl trinor PGF2 alpha amide was converted the amides of various PGs to the free acids. Woodward_DF et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|